When was Neuralight founded?

Neuralight was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Neuralight located?

Neuralight is headquartered in San Francisco, United States.

Who is the current CEO of Neuralight?

Edmund Benami of Neuralight. They have also founded 1 company.

How many employees does Neuralight have?

As of Sep 30, 2026, the latest employee count at Neuralight is 29.

Is Neuralight a funded company?

Neuralight is a funded company, having raised a total of $30.5M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 28, 2021.

When was the latest funding round of Neuralight?

Neuralight's latest funding was a $***** Series A round on May 24, 2022, with participation from 7 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $6.53B in funding in 2026 to date.

Where does Neuralight rank among its competitors?

Neuralight ranks 1st amongst 69 active competitors, of which 25 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was neuroClues, which secured $11.6M in Apr, 2026.

Who are the top competitors of Neuralight?

Neuralight's top competitors include neuroClues, NovaSight and Neurotrack. Among them, neuroClues secured the most recent funding round in April, 2026.

Neuralight - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.neuralight.ai/
Email ID: *****@neuralight.ai

Key Metrics

Founded Year

2021

Location

San Francisco, United States

Stage

Series A

Total Funding

$30.5M in 2 rounds

Latest Funding Round

Series A, May 24, 2022, $*****

Investors

Koch Disruptive Technologies & 18 more

Ranked

1^st among 69 active competitors

Employee Count

29 as on Sep 30, 2026

Similar Companies

neuroClues & 69 more

View Neuralight's full profile

Neuralight is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
NEURALIGHT INC. CIN: 6395784 , United States, Active	Feb 03, 2022	-	-	-

Neuralight has raised a total funding of $30.5M over 2 rounds. Its first funding round was on Oct 28, 2021. Its latest funding round was a Series A round on May 24, 2022 for $*****. 7 investors participated in its latest round. Neuralight has 12 institutional investors and 7 angel investors.

Here is the list of recent funding rounds of Neuralight:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 24, 2022	8784792	Series A	8899604	3729593	2138480	8937770
Oct 28, 2021	7513362	Seed	4961547	7867061	5499341	VSC Ventures & 10 more

Access funding benchmarks and valuations. Sign up today!

View details of Neuralight's funding rounds and investors

The founders of Neuralight are Gil Shklarski, Thomas C Sudhof and Edmund Benami. Edmund Benami is the CEO of Neuralight.

Here are the details of Neuralight's key team members:

Gil Shklarski: Investor, Board Observer, Scientific Co-Founder of Neuralight. They are also an angel investor in 4 startups.
Thomas C Sudhof: Co-Founder of Neuralight.
Edmund Benami: Co-Founder & CEO of Neuralight.
Contact Info: 1 email address

View details of Neuralight's Founder profiles and Board Members

Neuralight's employee count trend

Neuralight has 29 employees as of Sep 26. Here is Neuralight's employee count trend over the years:

Uncover Neuralight's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neuralight include neuroClues, NovaSight and Neurotrack. Here is the list of Top 10 competitors of Neuralight, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neuralight 2021, San Francisco (United States), Series A	AI-based neurological evaluation and assessment tool for diagonosis	$30.5M	Global Founders Capital, MS&AD Ventures & 17 others	57/100
2nd	neuroClues 2020, Louvain-la-neuve (Belgium), Series A	Provider of eye-tracking devices for healthcare practitioners	$21.8M	Graph Ventures, Europa & 11 others	54/100
3rd	NovaSight 2016, Lod (Israel), Series B	Provider of eye-tracking-based solutions for vision assessment and treatment	$20M	Rimonci, EIT Health	47/100
4th	Neurotrack 2012, Redwood City (United States), Series C	Provider of clinical assessment tool to diagnose neurological disorders	$57.8M	Khosla Ventures, Sozo Ventures & 17 others	47/100
5th	Senseye 2015, Austin (United States), Series B	Provider of a smartphone-based mental health diagnostic platform	$17.4M	Oracle, Wavemaker Partners & 5 others	46/100
6th	Araya Brain Imaging 2013, Chiyoda City (Japan), Series B	Neuroimaging technology and services	$9.3M	31VENTURES, Sumitomo Shoji Machinex Co.,Ltd. ... & 7 others	44/100
7th	Tobii Dynavox 1983, Danderyd (Sweden), Late Stage	Provider of assistive communication solution for differently abled people via eye-tracking	-	Vestar Capital Partners	44/100
8th	Oculogica 2013, New York City (United States), Series B	Eye tracking technology to detect traumatic brain injury (TBI)	$22M	TitletownTech, Sofia Fund & 8 others	43/100
9th	machineMD 2019, Bern (Switzerland), Seed	Developer of a device for the diagnosis of brain disease	$4.77M	Guido Fluri Stiftung, MassChallenge & 3 others	42/100
10th	C. Light Technologies 2014, Berkeley (United States), Seed	Developer of eye-tracking solution provider to detect and monitor neurodegenerative diseases	$3.25M	Creative Ventures, Alzheimer's Drug Discovery ... & 10 others	42/100